JUSTIN CHIANG: Open Payments
NPI 1396344610 · VALLEY STREAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,199 in 91 payments from 17 companies in 2025. Trend: 2023 $898 · 2024 $1,885 · 2025 $2,199
Food & beverage: $2,199
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 22 | $583 |
| GENZYME CORPORATION | 8 | $224 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $171 |
| PFIZER INC. | 8 | $161 |
| ARS Pharmaceuticals Operations, Inc. | 8 | $160 |
| GlaxoSmithKline, LLC. | 7 | $153 |
| Grifols USA, LLC | 5 | $132 |
| Incyte Corporation | 4 | $96 |
| Genentech USA, Inc. | 3 | $85 |
| ABBVIE INC. | 3 | $82 |
Products named: DUPIXENT, NEFFY, OCTAGAM IMMUNE GLOBULIN (HUMAN), Xembify, NUCALA, OPZELURA, GLASSIA, Xolair.
Industry payments across NY — which companies pay providers there.
